Kezar Life Sciences Inc - KZR Net Assets per Single Share

Public company logo of kezarlifesciences.com (KZR)

Kezar Life Sciences small molecule developments are protected by patents and complex R&D, although success depends on FDA verdicts. Therapy for chronic autoimmune pathologies guarantees long-term demand for drugs. However, capital burn and testing uncertainty create risks. The key book value indicator demonstrates net capital dynamics, while the value of 8.77 shows the latest value of this metric.

Accounting Value of a Share: Kezar Life Sciences Inc. (KZR) for 07/04/2022 - 05/23/2026

kezarlifesciences.com - analytical breakdowns and key metrics (KZR)

- price and consensus price forecast:
Price Chart Kezar Life Sciences, Inc|KZR - Fair Value Consensus
- market capitalization data:
Market Value Kezar Life Sciences, Inc.|KZR - Full Business Value
- book capitalization data:
Book Value per Share Kezar Life Sciences|KZR - Accounting Value of Company|Market Capitalization to Book Value Ratio kezarlifesciences.com|KZR - Company Total Assets
- debt and liquidity data:
Debt to Equity Kezar Life Sciences|KZR - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Kezar Life Sciences, Inc.|KZR - Company Total Debt|Debts to Book Capitalization Kezar Life Sciences, Inc.|KZR - Company Long-Term Debts|Company Current Liabilities Kezar Life Sciences
Analysis of all company metrics:Kezar Life Sciences, Inc (KZR)
Signature product of Kezar Life Sciences, Inc.

Book value per share reflects the portion of net assets attributable to a single security, measuring the company's actual equity minus all liabilities. Analyzing the historical book value per share chart enables portfolio stress testing, confirming the ability of Kezar Life Sciences (KZR) management to maintain disciplined resource management while developing innovative therapies for autoimmune diseases.

Competitor analysis

Net Assets per Single Share Argenx (ARGX)|BNTX: Accounting Value of a Share|Net Assets per Single Share Abivax Corp (ABVX)|admabiologics.com (ADMA) - Share Book Value|PTGX - Book Value per Share|Accounting Value of a Share Immunovant Inc|Book Value per Share KNSA|Book Value per Share GRFS (Grifols Biemat)|Net Assets per Single Share Adaptive Biotechnologies|celldex.com - Accounting Value of a Share|AUPH: Net Assets per Single Share|BCRX - Accounting Value per Share|VERA: Book Value per Share|Book Value per Share Dianthus Corp|PHVS - Accounting Value per Share|Accounting Value of a Share AbCellera Corp|TRML (Tourmaline Bio) - Book Value per Share|Net Assets per Share PGEN (Precigen Inc)|Pharming - Net Assets per Single Share|Nektar Corp - Accounting Value per Share|UPB: Net Assets per Single Share|zenasbio.com (ZBIO) - Accounting Value per Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio Inc) - Book Value per Share|Net Assets per Single Share KalVista Pharmaceuticals Inc (KALV)|Equity per Share Septerna Pharma|Pieris Pharmaceuticals - Book Value per Share|Net Asset Value per Share SVRA (savarapharma.com)|Net Assets per Single Share RIGL (Rigel Pharmaceuticals, Inc.)|Book Value per Share AnaptysBio Inc ANAB|ATXS (Astria Pharma) - Book Value per Share|enGene Corp (ENGN) - Net Asset Value per Share|Accounting Value per Share RAPT Therapeutics, Inc. (RAPT)|Aerovate Therapeutics (JBIO) - Share Book Value|ACRS (Aclaris Therapeutics, Inc.) - Book Value per Share|Book Value per Share KYTX|Tiziana Life Sciences PLC (TLSA) - Net Assets per Single Share|Accounting Value of a Share Cabaletta Bio Inc CABA|Accounting Value per Share Ventyx Biosciences|theratech.com - Accounting Value of a Share|AVTX - Net Assets per Single Share|ELDN - Net Assets per Single Share|Agenus Inc - Book Value per Share|Climb Bio, Inc (CLYM) - Net Assets per Share|Book Value per Share Zura Bio Limited ZURA|Share Book Value atyrpharma.com|Adagene - Book Value per Share|Net Asset Value per Share ikenaoncology.com IMA|Accounting Value per Share Shattuck Labs|Equillium Inc - Accounting Value of a Share|Net Assets per Single Share CNTB (Connect Pharma)|IMUX - Net Assets per Share|ATRA (atarabio.com) - Book Value per Share|InflaRx (IFRX) - Accounting Value per Share|XFOR: Book Value per Share|Net Assets per Share Adicet|Celularity Inc. - Book Value per Share|Net Asset Value per Share INMB (inmunebio.com)|BRNS - Net Assets per Single Share|Equity per Share SAB Biotherapeutics Inc. SABS|AKTX: Book Value per Share|ENLV - Accounting Value per Share|Book Value per Share QTTB|GOVX (geovax.com) - Net Asset Value per Share|EDSA: Net Assets per Single Share|Net Assets per Share IBIO|Net Assets per Single Share CARM|Book Value per Share XTL Bio XTLB|Bolt Biotherapeutics, Inc. (BOLT) - Accounting Value per Share|HCW Biologics, Inc. - Share Book Value|Net Assets per Single Share Aptevo (APVO)|AIM: Accounting Value of a Share|Net Assets per Single Share aditxt.com (ADTX)|GRI Bio Corporation (GRI) - Share Book Value|XRTX - Book Value per Share|Accounting Value of a Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share INDP (Indaptus Therapeutics Inc)|Net Assets per Single Share Scinai|CalciMedica Inc - Accounting Value of a Share|AFMD: Net Assets per Single Share|ALLK - Accounting Value per Share|HOOK: Book Value per Share|Book Value per Share IGM Biosciences|ITOS - Accounting Value per Share|Accounting Value of a Share Ocean Biomedical Corp|TCBP (TC Biopharm) - Book Value per Share|Net Assets per Share THRD (thirdharmonicbio.com)